Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effects of exosomes on premature menopause and return of menstruation in POF patients
IRCT20251118068036N2Phase 2Recruiting
- Sponsor
- Hamadan University of Medical Sciences
- Start
- May 2026
- Modality
- Lipid-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 2 trial of endothelial progenitor cell-derived exosomes in ovarian hypofunction (POI), sponsored by Hamadan University of Medical Sciences. Started May 2026; status: recruiting.
02
Drugs
endothelial progenitor cell-derived exosomes
03
Conditions
ovarian hypofunction (POI)
Beyond the preview
Go deeper on IRCT20251118068036N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20251118068036N2.